During the past decade, Manipal Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 13 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manipal Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Bio Products Laboratory" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manipal Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Government Medical College, Kozhikode" with 1 trials as a collaborator, "Institute for Child Health, Madras Medical College, Egmore, Chennai" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Manipal Hospital, India" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Manipal Hospital" are "Breast Cancer" (4 trials), "Diabetes Mellitus, Type 2" (2 trials), "Alcoholic Liver Cirrhosis" (1 trials), "Caloric Deficit" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Manipal Hospital" in a lesser frequency.

Most popular intervention types in "Manipal Hospital" are "Drug" (17 trials), "Biological" (4 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "13vPnC" (1 trials), "5-FU" (1 trials), "Abemaciclib" (1 trials) and "Active Comparator (erlotinib)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manipal Hospital" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Manipal Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Manipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Manipal Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

Manipal Hospital has several departments that took part in Clinical trials: "Manipal Hospital; Department of Oncology" - 5 trials, "Manipal Hospital & Manipal Institute for Neurological Disorders" - 2 trials